A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use
Publication Date
2016
Journal Title
J Oncol Pharm Pract
Abstract
Pomalidomide is an analog of thalidomide with immunomodulatory, anti-angiogenic, and anti-neoplastic activity indicated for the treatment of multiple myeloma refractory to at least two prior therapies. The incidence for renal failure was
Volume Number
22
Issue Number
2
Pages
357-60
Document Type
Article
EPub Date
2015/01/17
Status
Faculty, Northwell Researcher
Facility
School of Medicine; Northwell Health
Primary Department
Nephrology
Additional Departments
Hospital Medicine; Hematology/Medical Oncology
PMID
DOI
10.1177/1078155214568581